TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genetic Technologies ( (AU:GTG) ) has provided an update.
Genetic Technologies Limited has successfully completed its Deed of Company Arrangement (DOCA), marking its exit from external administration. The company’s existing directors have resigned, and new directors have taken control. Additionally, a Creditors’ Trust has been established, with creditors now becoming beneficiaries of this trust rather than creditors of the company. There is no expected return to unsecured creditors, but any potential returns will be communicated by the trustees.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its work in predictive genetic testing, which aims to provide insights into individual health risks and conditions.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
Learn more about GTG stock on TipRanks’ Stock Analysis page.